These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6083935)

  • 1. Osteolytic lesion in chronic myelogenous leukaemia.
    Frydecka I; Bieniek J; Brodzka W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):610-3. PubMed ID: 6083935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteolytic lesion in chronic myelogenous leukemia (CML). Initial manifestation of blastic crisis?
    Oppermann HC; Ludwig R; Georgi P
    Pediatr Radiol; 1979 Oct; 8(4):254-6. PubMed ID: 292968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone destruction in myelogenous marrow crisis.
    Braunstein EM; Hammond B; Schnitzer B
    J Can Assoc Radiol; 1980 Mar; 31(1):69-70. PubMed ID: 6928852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteolytic lesions in chronic myeloid leukemia. Report of three cases (author's transl)].
    Juncá Piera J; Durán Suárez JR; Triginer Boixeda J
    Med Clin (Barc); 1981 Mar; 76(6):259-61. PubMed ID: 6942204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone destructive foci as precursors of the blastic crisis in chronic myelocytic leukemia].
    Cavalli F; Pedrinis E; Mombelli G; Goldhirsch A; Reiner M
    Schweiz Med Wochenschr; 1977 Jun; 107(25):872-5. PubMed ID: 268024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal-phase chronic myelogenous leukemia: approaches to treatment.
    Allen SL; Coleman M
    Cancer Invest; 1985; 3(5):491-503. PubMed ID: 3902166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idarubicin in blastic crisis of chronic myelogenous leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortellaro M; Pozzoli E; Oriani A; Polli EE
    Haematologica; 1991; 76(5):406-8. PubMed ID: 1806446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.
    Amadori S; Picardi A; Fazi P; Testi AM; Petti MC; Montefusco E; Mandelli F
    Leukemia; 1996 May; 10(5):766-8. PubMed ID: 8656669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of chronic myelogenous leukemia in blastic crisis--vindesine, cytosine arabinoside prednisolone combination therapy].
    Uzuka Y; Saito Y; Takahash H; Komatsu M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1064-70. PubMed ID: 6586112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteolysis in chronic myeloid leukemia.
    Lambertenghi-Deliliers G; Castagnone D; Porro F; Cortelezzi A
    Tumori; 1978 Apr; 64(2):175-81. PubMed ID: 276965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intraosseous osteolytic lesions. Diagnostic, differential diagnosis and therapy (author's transl)].
    Adler CP; Wenz W
    Radiologe; 1981 Oct; 21(10):470-9. PubMed ID: 6946521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chloroma (granulocytic sarcoma, myeloblastoma). Clinical aspects and radiological diagnosis].
    Anders M; Düber C; Teifke A; Gamm H
    Rofo; 2000 Mar; 172(3):282-6. PubMed ID: 10778461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: report of one case.
    Yu HH; Lu MY; Lin DT; Lin KH; Tang JL; Jou ST
    Acta Paediatr Taiwan; 2006; 47(3):150-4. PubMed ID: 17078470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastic crisis in previously clinically silent chronic myelogenous leukemia.
    Mintz U; Bar-Meir S; Pinkhas J; De Vries A
    Haematologia (Budap); 1975; 9(3-4):257-60. PubMed ID: 1065616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
    Preisler HD; Raza A; Higby D; Kirshner J; Woll J; Bennett J; Winton L; Weiner R; Richman C; Golomb H
    Cancer Treat Rep; 1984 Nov; 68(11):1351-5. PubMed ID: 6388833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
    Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteolytic form of Paget's disease. Differential diagnosis and pathogenesis.
    Anderson JT; Dehner LP
    J Bone Joint Surg Am; 1976 Oct; 58(7):994-1000. PubMed ID: 977632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.